UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system (CNS) disorders (including epilepsy), inflammatory disorders (including allergy), and oncology. More information...
According to PR-model, ucb.com is ranked 129,848th in multilingual Wikipedia, in particular this website is ranked 103,747th in English Wikipedia.
The website is placed before aranetacity.com and after tineye.com in the BestRef global ranking of the most important sources of Wikipedia.